Eris Lifesciences Limited
NSE: ERIS.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Amit Indubhushan Bakshi
- Employees
- 3,620
- Headquarters
- Ahmedabad, India
- IPO year
- 2017
- Market cap
- ₹192.0B
- Website
- https://www.eris.co.in
Loading ERIS…
Loading profile data…Frequently asked questions about ERIS
What does Eris Lifesciences Limited (ERIS.NS) do?
Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, antidiabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/ana...
Where does ERIS.NS trade?
Eris Lifesciences Limited (ERIS.NS) trades on the National Stock Exchange of India.
What sector is ERIS.NS in?
Eris Lifesciences Limited (ERIS.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Eris Lifesciences Limited?
Amit Indubhushan Bakshi is the chief executive officer of Eris Lifesciences Limited (ERIS.NS).
Where is Eris Lifesciences Limited headquartered?
Eris Lifesciences Limited is headquartered in India.
Does ERIS.NS pay a dividend?
Yes — Eris Lifesciences Limited (ERIS.NS) paid a trailing twelve-month dividend of INR 14.70 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did ERIS.NS go public?
Eris Lifesciences Limited (ERIS.NS) completed its initial public offering in 2017.